These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3988968)

  • 1. Effects of carbamazepine on plasma haloperidol levels.
    Jann MW; Ereshefsky L; Saklad SR; Seidel DR; Davis CM; Burch NR; Bowden CL
    J Clin Psychopharmacol; 1985 Apr; 5(2):106-9. PubMed ID: 3988968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; Kaneko S
    J Clin Psychopharmacol; 2003 Oct; 23(5):435-40. PubMed ID: 14520118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
    Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Change in haloperidol level due to carbamazepine--a complicating factor in combined medication for schizophrenia.
    Kahn EM; Schulz SC; Perel JM; Alexander JE
    J Clin Psychopharmacol; 1990 Feb; 10(1):54-7. PubMed ID: 2106534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal lobe epilepsy with schizophrenia.
    Hejazi M
    South Med J; 1987 Aug; 80(8):1043-5. PubMed ID: 3616704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative efficacy of bromocriptine, carbamazepine and cyproheptadine with neuroleptics in 24 refractory chronic schizophrenic patients].
    Llorca PM; Wolf MA; Lançon C; Bougerol T
    Encephale; 1993; 19(5):565-71. PubMed ID: 8306925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significantly higher plasma haloperidol level during cotreatment with carbamazepine may herald cardiac change.
    Iwahashi K
    Clin Neuropharmacol; 1996 Jun; 19(3):267-70. PubMed ID: 8726546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The drug-drug interaction effects of haloperidol on plasma carbamazepine levels.
    Iwahashi K; Miyatake R; Suwaki H; Hosokawa K; Ichikawa Y
    Clin Neuropharmacol; 1995 Jun; 18(3):233-6. PubMed ID: 8635181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interindividual variation of plasma haloperidol concentrations and the impact of concomitant medications: the analysis of therapeutic drug monitoring data.
    Hirokane G; Someya T; Takahashi S; Morita S; Shimoda K
    Ther Drug Monit; 1999 Feb; 21(1):82-6. PubMed ID: 10051058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between carbamazepine and bromperidol.
    Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Suzuki A; Furukori H; Kaneko S; Inoue Y
    Eur J Clin Pharmacol; 1997; 52(3):219-22. PubMed ID: 9218929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of individual pharmacokinetic data for treatment of epilepsy with carbamazepine.
    Diehl LW; Müller-Oerlinghausen B; Riedel E
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):144-8. PubMed ID: 1002351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbamazepine: an efficient adjuvant treatment in schizophrenia].
    Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1992; 20(1):11-6. PubMed ID: 1502960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia.
    Kidron R; Averbuch I; Klein E; Belmaker RH
    Biol Psychiatry; 1985 Feb; 20(2):219-22. PubMed ID: 3971003
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carbamazepine: an effective adjuvant treatment in the schizophrenias].
    Martín Muñoz JC; Moriñigo Domínguez AV; Mateo Martín I; Guajardo-Fajardo Ibarra I; Noval Lamos D
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(4):245-50. PubMed ID: 2678932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing the relationship between carbamazepine plasma concentration and its clinical effects in patients with epilepsy.
    Rapeport WG
    Clin Neuropharmacol; 1985; 8(2):141-9. PubMed ID: 3924398
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adjuvant treatment of schizophrenic illness with carbamazepine].
    Hesslinger B; Klose P; Normann C; Langosch JM; Berger M; Walden J
    Fortschr Neurol Psychiatr; 1998 Apr; 66(4):145-50. PubMed ID: 9587773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses. A controlled study.
    Klein E; Bental E; Lerer B; Belmaker RH
    Arch Gen Psychiatry; 1984 Feb; 41(2):165-70. PubMed ID: 6365015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms?
    Arana GW; Goff DC; Friedman H; Ornsteen M; Greenblatt DJ; Black B; Shader RI
    Am J Psychiatry; 1986 May; 143(5):650-1. PubMed ID: 3963258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of varying haloperidol plasma levels on negative symptoms in schizophrenia and schizoaffective disorder.
    Volavka J; Cooper TB; Czobor P; Meisner M
    Psychopharmacol Bull; 1996; 32(1):75-9. PubMed ID: 8927679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primidone-carbamazepine interaction: clinical consequences.
    Benetello P; Furlanut M
    Int J Clin Pharmacol Res; 1987; 7(2):165-8. PubMed ID: 3583497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.